Innate Cells, an Alternative & Power Player in the Arsenal of Immunotherapy for Cancer Patients
Time: 10:00 am
day: Conference Day Two
Details:
- Activation of the innate immunity as alternative strategy for immuno-oncology
- Use of the innate cell engager to activate myeloid cells preferentially in the tumour microenvironment
- Activation of multiple immune cell populations to achieve stronger antitumour activity
